Carregant...
Low barrier buprenorphine treatment for persons experiencing homelessness and injecting heroin in San Francisco
BACKGROUND: Opioid overdose is a leading cause of death in persons experiencing homelessness (PEH), despite effective medications for opioid use disorder (OUD). In 2016, the San Francisco Street Medicine Team piloted a low barrier buprenorphine program with the primary goal of engaging and retaining...
Guardat en:
| Publicat a: | Addict Sci Clin Pract |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6501460/ https://ncbi.nlm.nih.gov/pubmed/31060600 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13722-019-0149-1 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|